{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:15:04Z","timestamp":1789787704995,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08342-4","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:25:03Z","timestamp":1779726303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting response to neoadjuvant chemotherapy combined with immunotherapy in gastric cancer based on habitat imaging and peritumoral radiomics: a two-center study"],"prefix":"10.1186","volume":"24","author":[{"given":"Chenjiao","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"8342_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"8342_CR2","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.3390\/cancers15143662","volume":"15","author":"V Tsagkalidis","year":"2023","unstructured":"Tsagkalidis V, Blaszczyk MB, In H. Interpretation of Tumor Response Grade following Preoperative Therapy for Gastric Cancer: An Overview. Cancers. 2023;15:3662. https:\/\/doi.org\/10.3390\/cancers15143662.","journal-title":"Cancers"},{"key":"8342_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/cancers12071749","volume":"12","author":"IV Zurlo","year":"2020","unstructured":"Zurlo IV, Basso M, Strippoli A, Calegari MA, Orlandi A, Cassano A, et al. Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren\u2019s Classification in Pan-Cancer Analysis Era? Cancers. 2020;12:1749. https:\/\/doi.org\/10.3390\/cancers12071749.","journal-title":"Cancers"},{"key":"8342_CR4","unstructured":"Deep learning nomogram for. predicting neoadjuvant chemotherapy response in locally advanced gastric cancer patients - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/38796795\/. Accessed 10 Dec 2025."},{"key":"8342_CR5","unstructured":"Accuracy of 18F-FDG PET\/CT. and CECT for primary staging and diagnosis of recurrent gastric cancer: A meta-analysis - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/33456531\/. Accessed 13 Dec 2025."},{"key":"8342_CR6","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.4251\/wjgo.v16.i10.4115","volume":"16","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wang Q, Guo T-H, Gao W, Yu Y-M, Wang R-F, et al. Computed tomography-based radiomic model for the prediction of neoadjuvant immunochemotherapy response in patients with advanced gastric cancer. World J Gastrointest Oncol. 2024;16:4115\u201328. https:\/\/doi.org\/10.4251\/wjgo.v16.i10.4115.","journal-title":"World J Gastrointest Oncol"},{"key":"8342_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","volume":"21","author":"JPB O\u2019Connor","year":"2015","unstructured":"O\u2019Connor JPB, Rose CJ, Waterton JC, Carano RAD, Parker GJM, Jackson A. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res Off J Am Assoc Cancer Res. 2015;21:249\u201357. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0990.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"8342_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2018180910","volume":"290","author":"N Beig","year":"2019","unstructured":"Beig N, Khorrami M, Alilou M, Prasanna P, Braman N, Orooji M, et al. Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas. Radiology. 2019;290:783\u201392. https:\/\/doi.org\/10.1148\/radiol.2018180910.","journal-title":"Radiology"},{"key":"8342_CR9","doi-asserted-by":"publisher","first-page":"e192561","DOI":"10.1001\/jamanetworkopen.2019.2561","volume":"2","author":"N Braman","year":"2019","unstructured":"Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, et al. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer. JAMA Netw Open. 2019;2:e192561. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.2561.","journal-title":"JAMA Netw Open"},{"key":"8342_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41467-025-56275-1","volume":"16","author":"A Perucca","year":"2025","unstructured":"Perucca A, Llon\u00edn AG, Benach OM, Hallopeau C, Rivas EI, Linares J, et al. Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing. Nat Commun. 2025;16:1279. https:\/\/doi.org\/10.1038\/s41467-025-56275-1.","journal-title":"Nat Commun"},{"key":"8342_CR11","unstructured":"Amin M, Edge S, Greene F, Byrd D, Brookland R, Washington M, Gershenwald J, Compton C, Hess K, Sullivan D, et al. AJCC cancer staging manual, 8th ed. (New York). 2017"},{"key":"8342_CR12","doi-asserted-by":"publisher","unstructured":"A Z MV, Ma A, Hjwl A. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295. https:\/\/doi.org\/10.1148\/radiol.2020191145.","DOI":"10.1148\/radiol.2020191145"},{"key":"8342_CR13","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1016\/j.acra.2025.04.005","volume":"32","author":"P Xu","year":"2025","unstructured":"Xu P, Yao F, Xu Y, Yu H, Li W, Zhi S, et al. Habitat Radiomics and Deep Learning Features Based on CT for Predicting Lymphovascular Invasion in T1-stage Lung Adenocarcinoma: A Multicenter Study. Acad Radiol. 2025;32:4860\u201370. https:\/\/doi.org\/10.1016\/j.acra.2025.04.005.","journal-title":"Acad Radiol"},{"key":"8342_CR14","doi-asserted-by":"publisher","first-page":"1559398","DOI":"10.3389\/fonc.2025.1559398","volume":"15","author":"X Yu","year":"2025","unstructured":"Yu X, Zou Y, Wang C, Wang L, Jiao J, Yu H, et al. Habitat-based radiomics for preoperative differentiation between early-stage serous borderline ovarian tumors and malignant ovarian tumors. Front Oncol. 2025;15:1559398. https:\/\/doi.org\/10.3389\/fonc.2025.1559398.","journal-title":"Front Oncol"},{"key":"8342_CR15","doi-asserted-by":"publisher","first-page":"1460426","DOI":"10.3389\/fonc.2024.1460426","volume":"14","author":"L Chen","year":"2024","unstructured":"Chen L, Wang Z, Meng Y, Zhao C, Wang X, Zhang Y, et al. A clinical-radiomics nomogram based on multisequence MRI for predicting the outcome of patients with advanced nasopharyngeal carcinoma receiving chemoradiotherapy. Front Oncol. 2024;14:1460426. https:\/\/doi.org\/10.3389\/fonc.2024.1460426.","journal-title":"Front Oncol"},{"key":"8342_CR16","doi-asserted-by":"publisher","first-page":"1541413","DOI":"10.3389\/fonc.2025.1541413","volume":"15","author":"B Guan","year":"2025","unstructured":"Guan B, Huang C, Wang Y, Zhang J, Li X, Hao Z. MRI-based habitat analysis of vascular and nerve invasion in the tumor microenvironment: an advanced approach for prostate cancer diagnosis. Front Oncol. 2025;15:1541413. https:\/\/doi.org\/10.3389\/fonc.2025.1541413.","journal-title":"Front Oncol"},{"key":"8342_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"Y-K Kang","year":"2022","unstructured":"Kang Y-K, Chen L-T, Ryu M-H, Oh D-Y, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23:234\u201347. https:\/\/doi.org\/10.1016\/S1470-2045(21)00692-6.","journal-title":"Lancet Oncol"},{"key":"8342_CR18","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"S-E Al-Batran","year":"2019","unstructured":"Al-Batran S-E, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet Lond Engl. 2019;393:1948\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(18)32557-1.","journal-title":"Lancet Lond Engl"},{"key":"8342_CR19","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.3390\/cancers14246235","volume":"14","author":"HJ van der Hulst","year":"2022","unstructured":"van der Hulst HJ, Vos JL, Tissier R, Smit LA, Martens RM, Beets-Tan RGH, et al. Quantitative Diffusion-Weighted Imaging Analyses to Predict Response to Neoadjuvant Immunotherapy in Patients with Locally Advanced Head and Neck Carcinoma. Cancers. 2022;14:6235. https:\/\/doi.org\/10.3390\/cancers14246235.","journal-title":"Cancers"},{"key":"8342_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13244-025-01985-9","volume":"16","author":"L Zhuo","year":"2025","unstructured":"Zhuo L, Chen W, Xing L, Li X, Song Z, Dong J, et al. MRI-based quantification of intratumoral heterogeneity for intrahepatic mass-forming cholangiocarcinoma grading: a multicenter study. Insights Imaging. 2025;16:101. https:\/\/doi.org\/10.1186\/s13244-025-01985-9.","journal-title":"Insights Imaging"},{"key":"8342_CR21","doi-asserted-by":"publisher","first-page":"1414954","DOI":"10.3389\/fimmu.2024.1414954","volume":"15","author":"G Ye","year":"2024","unstructured":"Ye G, Wu G, Zhang C, Wang M, Liu H, Song E, et al. CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer. Front Immunol. 2024;15:1414954. https:\/\/doi.org\/10.3389\/fimmu.2024.1414954.","journal-title":"Front Immunol"},{"key":"8342_CR22","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1038\/s41467-024-48310-4","volume":"15","author":"J Kang","year":"2024","unstructured":"Kang J, Lee JH, Cha H, An J, Kwon J, Lee S, et al. Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types. Nat Commun. 2024;15:4067. https:\/\/doi.org\/10.1038\/s41467-024-48310-4.","journal-title":"Nat Commun"},{"key":"8342_CR23","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpha.2023.07.003","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Jiang X, Wang X, Huang J, Li T, Jin H, et al. Promise of spatially resolved omics for tumor research. J Pharm Anal. 2023;13:851\u201361. https:\/\/doi.org\/10.1016\/j.jpha.2023.07.003.","journal-title":"J Pharm Anal"},{"key":"8342_CR24","doi-asserted-by":"publisher","first-page":"e2413702","DOI":"10.1002\/advs.202413702","volume":"12","author":"Y-H Huang","year":"2025","unstructured":"Huang Y-H, Shi Z-Y, Zhu T, Zhou T-H, Li Y, Li W, et al. Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer. Adv Sci Weinh Baden-Wurtt Ger. 2025;12:e2413702. https:\/\/doi.org\/10.1002\/advs.202413702.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"8342_CR25","doi-asserted-by":"publisher","first-page":"9129","DOI":"10.1007\/s00432-023-04709-y","volume":"149","author":"Y-K Wang","year":"2023","unstructured":"Wang Y-K, Lv X-X, Wang Z-Q, Zhou Y-M, Jiang B, Wang S-N, et al. The significance of the microlymphangiogenesis, microangiogenesis, and combined detection of programmed cell death-1 protein (PD-1)\/ki67 in gastric cancer tissues. J Cancer Res Clin Oncol. 2023;149:9129\u201337. https:\/\/doi.org\/10.1007\/s00432-023-04709-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8342_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"key":"8342_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782\u201395. https:\/\/doi.org\/10.1016\/j.immuni.2013.10.003.","journal-title":"Immunity"},{"key":"8342_CR28","doi-asserted-by":"publisher","first-page":"1396808","DOI":"10.3389\/fimmu.2024.1396808","volume":"15","author":"H Sun","year":"2024","unstructured":"Sun H, Liu Y, Cheng W, Xiong R, Gu W, Zhang X, et al. The distribution and maturation of tertiary lymphoid structures can predict clinical outcomes of patients with gastric adenocarcinoma. Front Immunol. 2024;15:1396808. https:\/\/doi.org\/10.3389\/fimmu.2024.1396808.","journal-title":"Front Immunol"},{"key":"8342_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"key":"8342_CR30","unstructured":"Computed tomography radiomics to. predict microsatellite instability status and immunotherapy response in gastric cancer - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/40813941\/. Accessed 13 Dec 2025."},{"key":"8342_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12885-025-13450-3","volume":"25","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Zhu J, Xie H, Wang Z, Huang Z, Su M. Intratumoral and peritumoral radiomics for forecasting microsatellite status in gastric cancer: a multicenter study. BMC Cancer. 2025;25:66. https:\/\/doi.org\/10.1186\/s12885-025-13450-3.","journal-title":"BMC Cancer"},{"key":"8342_CR32","unstructured":"Intratumoral. and peritumoral radiomics predict pathological response after neoadjuvant chemotherapy against advanced gastric cancer - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/38270724\/. Accessed 13 Dec 2025."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08342-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08342-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:00:00Z","timestamp":1779872400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08342-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8342"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08342-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by our Institutional Review Board, and the requirement for informed consent was waived (Approval No: SDTHEC20251102). The study was conducted in accordance with the revised guidelines of the Declaration of Helsinki (2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"706"}}